TQC2938 Placebo

DRUG2 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Conditions

AsthmaSeasonal Allergic Rhinitis

Phase 1

A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects

Active, not recruitingNCT06449859

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Asthma

Start: 2023-06-13End: 2024-11-30Target: 84Updated: 2024-06-10

Phase 2

Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis

CompletedNCT07052097

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Seasonal Allergic Rhinitis

Start: 2025-07-31End: 2025-11-28Updated: 2026-02-10